Shepherd Kaplan Krochuk’s BioLife Solutions BLFS Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$399K	–	188
2020 Q4	$399K	Sell	10,000 -3,200	-24%	-$109K	0.15%	110
2020 Q3	$382K	Hold	13,200	–	–	0.16%	101
2020 Q2	$216K	Buy	+13,200	New	+$182K	0.1%	149
2020 Q1	–	Sell	-14,000	Closed	-$227K	–	140
2019 Q4	$227K	Hold	14,000	–	–	0.17%	133
2019 Q3	$233K	Hold	14,000	–	–	0.17%	135
2019 Q2	$237K	Hold	14,000	–	–	0.17%	133
2019 Q1	$250K	Hold	14,000	–	–	0.16%	142
2018 Q4	$168K	Hold	14,000	–	–	0.12%	150
2018 Q3	$245K	Sell	14,000 -2,000	-13%	-$39.6K	0.13%	164
2018 Q2	$183K	Buy	+16,000	New	+$146K	0.11%	173

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Shepherd Kaplan Krochuk's BLFS Position: Q1 2021 in Review

Shepherd Kaplan Krochuk sold out of BioLife Solutions (BLFS) in Q1 2021, closing a stake of 10,000 shares — an estimated $399K sold.

Shepherd Kaplan Krochuk first reported a position in BLFS in Q2 2018 and held it in 10 quarters. The position peaked at $399K in Q4 2020. 132 funds tracked by Wall St. Rank hold BLFS as of Q1 2021.

Shepherd Kaplan Krochuk reported no remaining BioLife Solutions position as of Q1 2021 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 10,000 BioLife Solutions shares in Q1 2021, an estimated $399K.
Shepherd Kaplan Krochuk first reported a position in BioLife Solutions in Q2 2018 and held it in 10 quarters.
Shepherd Kaplan Krochuk's BioLife Solutions position peaked at $399K in Q4 2020.
132 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2021.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2021, filed 17 May 2021.